Access links:
CONTENT
Destacados
HIVACAT
Projects
- Actiu
CUTHIVAC Cutaneous HIV Vaccination
The CUT’HIVAC project is an innovative needle-free vaccination strategy across the skin to combat HIV and other infectious diseases.
Funded by the European...
Financing entity: European Comission
Participant entities: Universite Pierre et Marie Curie, University of Regensburg, FIT Biotech Oy Ltd, CHARITE, St George’s University of London, MRC Medical Research Council, IMPACTA, Centre National de la Recherche Scientifique, INSERM, Instituto Nacional de Saúde, GENEART AG, NOVAMEN
Date: 01/01/2010
Research Supervisor(s): Christian Brander
Also related to: HIVACATInmunidad Celular y Genética del huésped
- Actiu
Conserved Elements on HIV
Financing entity: Bill & Melinda Gates Foundation
Participant entities:
Date: 01/01/2009
Research Supervisor(s): Christian Brander
Also related to: HIVACAT
- Actiu
A phase II study of use of autologous myeloid dendritic cells as cellular adjuvant for a therapeutic vacine against the type I immunodeficiency virus in patients at early stages of HIV-1 infection
Orvacs Manon07 CP004142
Financing entity: ORVACS
Participant entities:
Date: 01/01/2009
Also related to: HIVACAT
- Actiu
Estudio en fase I de inmunogenicidad y seguridad de una vacuna preventiva para el VIH basada en vectores poxviurus que expresa proteinas env, gag, pol y nef del VIH-1 subtipo B en individuos no infectados”
PI 061468
Financing entity: FIS
Participant entities: Hospital Clínic de Barcelona
Date: 01/01/2009
Also related to: HIVACAT
- Actiu
Optimización como inmunógeno de la proteína de la envuelta del virus de la inmunodeficiencia humana tipo 1
FP36780/08
Financing entity: Fundación para la Investigación y la Prevención del SIDA en España (FIPSE)
Participant entities:
Date: 01/01/2009
Also related to: HIVACAT
